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Lutein and zeaxanthin are carotenoids found in green
leafy vegetables with interesting antioxidant properties.
They are present in high concentrations in the fovea
centralis of the human retina and their role in the pre-
vention of age-related macula degeneration has been re-
ported. We have investigated the e¡ect of orally
administered lutein and zeaxanthin in the cutaneous re-
sponse to ultraviolet B irradiation. Female hairless SKh-
1 mice receiving 0.4% and 0.04% lutein plus zeaxanthin-
enriched diet for 2 wk were exposed to single doses of
ultraviolet B radiation. Skin biopsies were taken at 24
and 48 h after irradiation and analyzed for the presence
of apoptotic cells, proliferating cells, and expression of
proliferating cell nuclear antigen. Our results show a
clear ultraviolet-induced dose-dependent in£ammatory
response. Orally administered 0.4% lutein and zeax-
anthin decreased signi¢cantly the edematous cutaneous
response (po0.01) as determined by the reduction of the
UVB-induced increase of ear bifold thickening. Addi-
tionally, dietary carotenoids were e⁄cient in reducing
the ultraviolet B-induced increases in the percentage of
proliferating cell nuclear antigen (po0.05), bromodeox-
yuridine (po0.05), and terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate nick
end-labeling-positive cells (po0.01). These data demon-
strate that oral supplementation of lutein and zeax-
anthin diminishes the e¡ects of ultraviolet B irradia-
tion by reducing acute in£ammatory responses and ul-
traviolet-induced hyperproliferative rebound. Key
words: antioxidants/carotenoids/lutein and zeaxanthin/oral
photoprotection. J Invest Dermatol 121:399 ^405, 2003
T
he acute responses of human skin to solar ultraviolet
(UV) radiation (l, 290^400 nm) are recognized as a
form of in£ammatory reaction that are mediated by
several possible mechanisms, including: (1) a direct
action of absorbed photons on DNA of viable nuclei
of skin cells (Cadet andVigny, 1990; Cadet et al, 1992;Tedesco et al,
1997); (2) the generation of reactive oxygen species (ROS) and
free radicals (e.g., superoxide anion (O2
^), singlet oxygen (1O2),
hydroxy (OH), or peroxy radicals (OOH)) (Pathak and Stratton,
1968; Athar et al, 1992; Dalle Carbonare and Pathak, 1992); and (3)
the generation of prostaglandins (PGD2, PGE2), histamines, leu-
kotrienes, and other cytokines (Black et al, 1980; Hawk et al, 1983;
Pentland and Needleman, 1986; Kupper, 1990; Soter, 1990; Norris
et al, 1993; Tedesco et al, 1997). It is conceivable that these UV-in-
duced reactions represent oxidative stress reactions of DNA bases,
lipids, and proteins mediated by the formation of free radicals
and ROS, liberation of membrane phospholipids, membrane li-
pid peroxidation, and subsequent formation of prostaglandins as
well as other cytokines by cyclooxygenase- and lipoxygenase-
mediated pathways (Black et al, 1980; Hawk et al, 1983; Pentland
and Needleman, 1986; Pentland and Jacobs, 1991).
Several studies have been reported to indicate that a number of
UV-mediated cutaneous in£ammatory reactions (e.g., sunburn,
skin phototoxic reaction involving drug-induced photosensitiza-
tion, epidermal edema, and vesicle formation) can be partially in-
hibited or minimized by systemic administration of antioxidants,
such as vitamin C (ascorbic acid), vitamin E (a-tocopherol), b-
carotene, polyphenolic antioxidants and iso£avones, and other
compounds (Mathews-Roth et al, 1970, 1972; Greenberg et al,
1990; Gerrish and Gensler, 1993; Wang et al, 1994; Darr and Pin-
nell, 1997). Although this search has recently widened to include
cosmetic bene¢ts, nutraceutical and therapeutic interventions
(e.g., in skin photoaging, skin carcinogenesis), only a few com-
pounds of antioxidant nature (e.g., polyphenolic antioxidants si-
lymarin from milk thistle, epigallocatechin-3-gallate from green
tea, and iso£avone) appear to be promising in the chemopreven-
tion of UV-induced skin damage (Wang et al, 1994, 1998; Wei,
1998; Lahiri-Chatterjee et al, 1999).
In recent years, our interest has broadened for minimizing or
preventing the acute and chronic reactions of skin to UV radia-
tion using hitherto poorly recognized antioxidants of plant
origin such as lutein and zeaxanthin to prevent or minimize
the harmful e¡ects of UV radiation involving ROS. Although
b-carotene has been used in the past against sunburn reaction
and porphyrin-induced cutaneous photosensitization reaction in
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patients with erythropoietic protoporphyria and healthy indivi-
duals (Mathews-Roth et al, 1970, 1972), its use has been shown to
be of limited success in UV-induced in£ammation (Darr and
Pinnell, 1997). Lutein, a major xanthophyll carotenoid, is structu-
rally related to b-carotene and appears to have superior antioxi-
dant properties compared with b-carotene (O’Connor and
O’Brien, 1998). Lutein and zeaxanthin are found in high concen-
trations in several fruits and green-leafed vegetables, such as broc-
coli, spinach, kale, cabbage, and green mustard leaves, etc.
Additionally, these xanthophyll carotenoids have been identi¢ed
to accumulate in human skin (Wingerath et al, 1998).
In this communication, we report a potentially bene¢cial
in-vivo property of this naturally occurring antioxidant agent in
photoprotection of murine skin against harmful e¡ects of UVB
radiation. These photoprotective e¡ects include: inhibition of
UVB-induced acute in£ammatory responses, decreased number
of UVB-induced apoptotic sunburn cells, reduction in UV-in-
duced hyperproliferative response as shown by decreased number
of proliferating cell nuclear antigen (PCNA) and bromodeoxyur-
idine (BrdU)-positive cells in the epidermis of lutein and zeax-
anthin fed mice. Because UV-induced in£ammation and
hyperproliferation (Black et al, 1980; Hawk et al, 1983; Pentland
and Needleman, 1986; Pentland and Jacobs, 1991) have been
strongly involved in UVB carcinogenesis, inhibitory e¡ects of
dietary lutein and zeaxanthin on acute in£ammation and epider-
mal hyperproliferation may have a potential implication for the
prevention of carcinogenesis in chronically irradiated skin.
MATERIALS AND METHODS
Mice and diets Twenty-¢ve female SKH-1 mice, 6 to 8 wk of age, were
purchased from Charles River Laboratories (Wilmington, Massachusetts).
Mice were housed in our animal housing facility under controlled
temperature and humidity, and alternating 12 h light and dark cycles for a
period of 2 wk before use. Mice received drinking water ad libitum. They
were housed into groups of four animals per cage and put into three
di¡erent groups according to the diet administered. Mice of group I
(n¼ 9) were fed with the standard diet of Purina Rodent Chow 5001;
mice of group II (n¼ 8) were fed with Purina Rodent Chow 5001
enriched with 0.04% lutein and zeaxanthin and mice of group III (n¼ 8)
received Purina Rodent Chow 5001 enriched with 0.4% lutein and
zeaxanthin. Crystalline FloraGLO brand lutein was provided in a stable
form by Kemin Foods, L.C. (DesMoines, Iowa). This material contains
lutein and zeaxanthin in a ratio of approximately 20:1. FloraGLO brand
lutein is a puri¢ed source of lutein and zeaxanthin, which is
manufactured and sold commercially according to a patented process. (US
patent no. 5382 714) and is the only pure product available for oral
supplementation, and was used in our studies without further separation.
The diets were prepared by Research Diets Inc. (New Brunswick, New
Jersey) and packed under vacuum in evacuated and sealed plastic bags,
each containing 100 g of diet in pellet form. The dietary bags enriched
with 0.4% and 0.04% lutein and zeaxanthin were refrigerated at 41C to
preserve the carotenoids. These concentrations were recommended by
nutritional experts (Professor Curran-Celentano, personal communication).
Mice were fed on alternate days for a total of 14 d prior to UVB exposure.
The study aimed to evaluate the photo protective e¡ects of dietary lutein
supplementation was approved by our Institutional Animal Care and Ethic
Committee and carried out in observance of the NIH Guidelines for the care
and use of laboratoryAnimals.
UVB exposure Mice were irradiated using a Spot Light Source
Radiation (Model L2859-07, Hamamatsu Photonics K. K., Japan),
equipped with a cut-o¡ ¢lter at 295 nm. UV radiation was delivered
through a bundle of quartz optical ¢bers with a spot size of 1 cm in
diameter. The emitted UVB radiation was measured with a
spectroradiometer (model 742, Optronic Laboratories Inc., Orlando,
Florida). The spectral output of this lamp was maximal at 310 nm with
the majority of the UVB energy emitted below 320 nm. The ¢ltered UV
radiation was calibrated and measured with the aid of an IL1700 research
radiometer equipped with an SED 240 UVB detector probe
(International Light, Newburyport, Massachusetts).
Two weeks before UVB exposure, all mice were tattooed on lateral skin
of the dorsum surface for carefully locating the irradiation exposure sites
and for obtaining skin biopsies of the exposed skin sites. The mice were
then exposed at duplicate sites to single doses of 40, 80, and 160 mJ per
cm2 of UVB radiation at the previously marked skin areas of the dorsal
surface. Of note, 1 minimum erythema dose for skin phototype III is
about 30 mJ per cm2.
Skin edema To assess the e¡ect of p.o. administered lutein and
zeaxanthin on UVB-induced skin in£ammation and edema, ears of mice
were exposed to 40 and 160 mJ per cm2 of UVB radiation and the increases
in skin-bifold thickness of the irradiated ears were measured at 24 h in a
blinded manner. In doing this, the ear skin double fold thickness was
determined using a Vernier Caliper micrometer (Scienceware,
Switzerland). The increase in ear-bifold thickness of ears was calculated by
subtracting the baseline values obtained prior to UV exposure.
Isolation of skin samples From each experimental group, half of the
experimental animals receiving UVB radiation were killed at 24 h and the
remaining were killed at 48 h after UVB irradiation using IACUC
(Institutional Animal Care and Use Committee) approved techniques of
euthanasia. In each animal, 6 mm skin biopsies were obtained from the
UVB-exposed skin sites and from nonirradiated skin. One skin specimen
obtained from each exposure dose was immediately ¢xed in 10% bu¡ered
formaldehyde for para⁄n-embedded sections, and the other skin specimen
was immediately stored at ^801C for western blot studies.
Terminal deoxynucleotidyl transferase nick end labeling (TUNEL)
assay UVB-irradiated skin specimens were examined for the presence of
apoptotic cells by the TUNEL assay. This assay identi¢es apoptotic cells
and allows to quantify reliably the number of TUNEL-positive cells.We
used ApopTag Fluorescein In Situ Apoptosis detection kit (S7110,
Intergenco, Inc., Purchase, New York; www.intergenco.com). This kit
labels digoxigenin-labeled 30 -OH ends of the genomic DNA. Brie£y, 5
mm sections were depara⁄nized with xylene, treated with series of graded
alcohols, washed once in phosphate-bu¡ered saline and subsequently
treated with proteinase K (Sigma, St Louis, Missouri; www.sigma-
aldrich.com) (20 mg per mL) for 15 min at 371C. After proteinase
digestion, sections were incubated with 75 mL equilibration bu¡er for 10 s.
Sections were then incubated in a humidi¢ed chamber with terminal
deoxynucleotidyl transferase enzyme for 1 h at 371C. Incubation of one
section with phosphate-bu¡ered saline was used as a negative control. The
sections were then soaked in working strength stop/wash bu¡er, agitated
for 15 s and rinsed in three changes with phosphate-bu¡ered saline. After
rinsing, sections were incubated with anti-digoxigenin £uorescein for
30 min at room temperature. Finally, sections were rinsed with three
washes of phosphate-bu¡ered saline and counterstained with propidium
iodide/anti-fade. The slides were viewed under a £uorescence microscope
equipped with a l¼ 380^420 nm emission ¢lter (Axiophot, Goº ttingen,
Germany). TUNEL-positive cells were counted using a 40 objective
lens on ¢ve randomly selected ¢elds per section. A total of three sections
per sample were analyzed.
Immunohistochemistry staining for PCNA Immunohistochemical
assays were performed using mouse anti-human PCNA antibody clone
PC10 (cat. no. M 0879, DAKO, Glostrup, Denmark) and a M.O.M. kit
staining procedure (Vector Laboratories, Burlingame, California;
www.vectorlabs.com). Brie£y, 5 mm thick sections were depara⁄nized
and hydrated slowly with xylene and graded alcohol series and
subsequently rinsed for 5 min in water. After appropriate antigen
unmasking by using standard techniques, the endogenous peroxidase
activity was blocked by incubating the skin sections with 3% hydrogen
peroxide in water for 5 min. Then avidin/biotin blocking was applied and
sections were incubated for 1 h in working solution of M.O.M. mouse
immunoglobulin blocking reagent. Next, sections were incubated with
mouse anti-human PCNA monoclonal antibody diluted 1:1000 in
M.O.M. diluent for 4 h at room temperature. Slides were rinsed with
phosphate-bu¡ered saline, and subsequently incubated with working
solution of M.O.M. biotinylated anti-mouse IgG reagent for 10 min at
room temperature. ABC reagent (Vectastain, Vector Laboratories) was
added to sections for 5 min 3,30 -diaminobenzidine (Sigma) peroxidase
substrate solution was used as a chromogen followed by a light
counterstaining with Mayer’s hematoxylin (Vector Laboratories) for 1
min, cleared with xylene, mounted with a coverslip and examined under
a light microscope. Cells showing a brown nuclear reaction indicated
proliferating cells and were considered PCNA positive. The slides were
examined and scored under a light microscope. PCNA-positive and
PCNA-negative cells in every randomly selected ¢eld were counted using
a 20 objective lens. Labeling index was calculated as the percentage of
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PCNA-positive keratinocytes speci¢cally in the basal cell layer. A total of
¢ve ¢elds per slide and three slides per sample were evaluated.
BrdU incorporation into DNA BrdU, a thymidine analog that is
incorporated into proliferating cells mainly during the S-phase of DNA
synthesis, was detected by a biotinylated mouse monoclonal anti-BrdU
antibody (Olsen and Kirkhus, 1989) (Clone BU 33, product no. B2531,
Sigma) and a M.O.M. kit staining procedure (Vector Laboratories).
Brie£y, all animals were intraperitoneally injected with BrdU (Sigma) in
normal saline (50 mg per kg) and killed 1 h after injection. Sections from
all skin samples were prepared as described above for PCNA immuno-
histochemistry. Endogenous peroxidase was blocked by incubating
the sections in 3% hydrogen peroxide in methanol for 10 min at room
temperature. DNA denaturation was achieved by incubating sections in 2
M HCl for 30 min at 371C. Slides were rinsed thoroughly in phosphate-
bu¡ered saline and incubated in a moist chamber with 0.1% trypsin for 10
min at 371C; they were then incubated with mouse monoclonal anti-BrdU
antibody. Subsequent steps were performed similar to PCNA staining
described above. The slides were examined and scored under a light
microscope using a 20 objective lens. The BrdU labeling index (LI) was
calculated from the number of stained BrdU-positive cells per 100 basal
cells counted in each ¢eld. A total of ¢ve ¢elds per section, and three
sections per sample were analyzed.
Western blot analysis Epidermal sheets were separated by incubating
skin biopsies in 6 M NaBr solution for 1 to 2 h. Only separated epidermis
was processed for homogenization and subsequent western blot analysis.
Next, proteins were extracted with a lysis bu¡er consisting of 0.25 M
Tris^HCl (pH 7.5), 0.375 M NaCl, 2.5% sodium deoxycholate, 1% Triton
X-100, 25 mM MgCl2, 1 mM phenylmethyl sulfonyl £uoride, and 0.1 mg
aprotinin per mL as described byYaar et al (1991). Equal amounts of protein
extract (50 mg), quanti¢ed by Bradford method were processed for western
blot analysis (Goukassian et al 2000). Antibody reactions were performed
with 1:200 dilutions of a⁄nity-puri¢ed mouse monoclonal and rabbit
polyclonal antibodies. Anti-PCNA (Ab-2) (Oncogene Science Inc.,
Cambridge, Massachusetts) was used as primary antibody. The secondary
rabbit and donkey anti-mouse antibodies (Santa Cruz Biotechnology, Inc,
Santa Cruz, California) were used at 1:2000 dilution. Equal protein loading
in each lane was con¢rmed by hybridization with a 1:2000 dilution of b-
actin antibody (Santa Cruz Biotechnology, Inc.). Antibody binding was
detected by ECL detection kit (Amersham, Piscataway, New Jersey),
followed by autoradiography (Kodak X-Omatic AR, Rochester, New
Jersey). Autoradiographs of western blots were scanned (Microtek Scan
Maker II, Taiwan) and band intensity was quanti¢ed after background
subtraction by using densitometric program ‘‘Sigma gel’’ (Jandel Scienti¢c,
Corte Madera, California). Normalization for loading of the lanes was
determined by Coomassie blue staining using multiple lanes.
Statistical analyses Results are expressed as the mean7SD. Data were
evaluated by two-tailed unpaired Student’s t test and analysis of variance
using the StarView statistical program. The level of statistical signi¢cance
was taken as po0.05.
RESULTS
Oral administration of lutein and zeaxanthin suppresses
UVB-induced skin in£ammation To evaluate the protective
e¡ect of oral administration of lutein and zeaxanthin against
UVB-induced in£ammation we measured ear skin bifold-
thickness. Animals fed with diet enriched with lutein and
zeaxanthin at 0.4% (striped bars) were found to have a
signi¢cantly suppressed edematous response induced by UVB
radiation (po0.001). Values of ear thickness increase in
millimeters after UVB exposure of untreated and lutein and
zeaxanthin-treated mice are shown in Fig 1.
Oral administration of lutein and zeaxanthin decreases the
number of UVB-induced apoptotic keratinocytes The
presence of apoptotic keratinocytes was assessed in skin biopsies
obtained at 24 and 48 h after UVB irradiation by using the
TUNEL assay. Immuno£uorescence microphotographs of
representative control irradiated skin (Fig 2a1) and irradiated
skin from mice fed with 0.04% (Fig 2a2) and 0.4% (Fig 2a3)
lutein and zeaxanthin supplemented diets are shown. When a
dose of either 80 or 160 mJ per cm2 of UVB irradiation was
used, almost all the cells in epidermis became TUNEL positive
(data not shown) and the number of apoptotic cells per ¢eld in
the epidermis of control (clear bars, Fig 2b) irradiated animals
increased in a dose-dependent manner. In mice fed with lutein
and zeaxanthin at 0.04% (black bars, Fig 2b) for 2 wk before
UVB irradiation, the number of TUNEL-positive cells induced
by 40 mJ per cm2 of UVB radiation was signi¢cantly reduced
(po0.01). This reduction was even greater (by 210%, po0.001)
when mice were fed with lutein and zeaxanthin at 0.4% (striped
bars Fig 2b). This reduction in the number of apoptotic cells was
similar in specimens obtained at 24 and 48 h (Fig 2b).
Oral administration of lutein and zeaxanthin decreases the
number of UVB-induced PCNA-positive cells in murine
skin To determine whether dietary administration of lutein
and zeaxanthin a¡ects epidermal cell proliferation after UVB
irradiation, skin biopsies from irradiated and nonirradiated skin
of mice were examined for PCNA expression by immuno-
histochemical and western blot analyses. In nonirradiated skin of
mice receiving a normal diet, the PCNA immunoreactivity was
limited to the basal layer (Fig 3a1). Strong nuclear
immunostaining was detected throughout the entire epidermis
of UV irradiated control (Fig 3a2) and mice fed with 0.04%
(Fig 3a3) and 0.4% (Fig 3a4) lutein and zeaxanthin.
Signi¢cantly higher numbers of PCNA-positive cells, however,
were observed in control versus lutein and zeaxanthin fed
animals (Fig 3a2,a3,a4) consistent with UV-induced
hyperproliferative response. To estimate the PCNA labeling
index in our studies we counted only the basal PCNA-positive
keratinocytes. At 24 and 48 h after exposure to UVB radiation,
there was a UVB dose-dependent increase in PCNA labeling
index (Fig 3b). Oral administration of diets enriched with lutein
and zeaxanthin at 0.04% (black bars) or 0.4% (striped bars) for 2
wk before irradiation with 40 mJ per cm2 reduced the percentage
of basal PCNA-positive cells by 35% and 14%, respectively.
Compared with control fed animals (clear bars), PCNA labeling
index was signi¢cantly reduced for all UVB doses at both time
points (po0.05) (Fig 3b). PCNA protein expression was also
examined by western blot analysis. (Fig 4b) There was a
statistically signi¢cant decrease compared with control in PCNA
protein levels in 0.4% (striped bars) lutein and zeaxanthin fed
Figure1. E¡ects of dietary 0.4% and 0.04% lutein and zeaxanthin
supplementation against UVB-induced ear swelling as outlined in
Materials and Methods. The clear bar corresponds to control animals of
group I, fed with normal diet, the black bar corresponds to animals of
group II receiving dietary lutein and zeaxanthin in a concentration of
0.04% and the striped bar correlates to group III receiving a dietary supple-
mentation of 0.4% lutein and zeaxanthin. X-axis shows UVB £uences in
mJ per cm2, Y-axis indicates the increase in ear bifold thickness in mm
(nnnpo0.001 vs control, irradiated mice of group I, fed with normal diet).
ORAL LUTEIN INHIBITS UVB-INDUCED EPIDERMAL HYPERPROLIFERATION 401VOL. 121, NO. 2 AUGUST 2003
Figure 2. E¡ects of oral administration
of 0.4% and 0.04% lutein and zeaxanthin
on UVB-induced increase in TUNEL-
positive cells. Female SKh-1 mice were fed
with either normal diet or diet supplemented
with lutein and zeaxanthin and killed at 24 h
or 48 h after UVB irradiation. (a) TUNEL-
stained sections from skin sites of unirra-
diated (a1) and irradiated control (a2) ani-
mals, and animals treated with 0.04% (a3)
and 0.4% (a4) lutein and zeaxanthin after ex-
posure to 40 mJ per cm2 of UVB radiation.
Original magni¢cation 200. (b) Graphic
representation of the percentage of TU-
NEL-positive cells observed at 24 h (left pa-
nel) and 48 h (right panel) after exposing skin
sites to 40 mJ per cm2. Clear bar represents
data of group I, who received no supplemen-
tation with lutein and zeaxanthin, the black
bar corresponds to group II receiving dietary
lutein and zeaxanthin in a concentration of
0.04% and the striped bar corresponds to
group III with a dietary supplementation of
0.4% lutein and zeaxanthin. X-axis represents
UVB doses at both 24 and 48 h time points
after the UVB exposure andY-axis represents
the number of TUNEL-positive cells per
40X ¢eld of view. Each bar represents the
mean value of six mice7SD (npo0.05)
Figure 3. E¡ects of oral administration of lutein and zeaxanthin on UVB-induced increase in PCNA-positive cells. (a) Mice were killed at 24 h
or 48 h after irradiation. Skin biopsies were taken immediately after exposure for PCNA immunohistochemical staining. PCNA-stained sections from uni-
rradiated (a1) and irradiated (a2) control animals and from irradiated animals treated with 0.04% (a3) and 0.4% (a4) lutein and zeaxanthin (24 h after 40 mJ
per cm2 of UVB radiation). Original magni¢cation  200. (b) Graphical representation of the immunohistochemical analysis of PCNA protein expression
in UVB-irradiated mouse skin fed with either normal diet or 0.4% and 0.04% lutein and zexanthin enriched diet. Clear bar represents data of group I, who
received no supplementation of diet with lutein and zeaxanthin, the black bar corresponds to group II receiving dietary lutein and zeaxanthin in a concen-
tration of 0.04% and the striped bar correlates to group III with a dietary supplementation of 0.4% lutein and zeaxanthin. X-axis represents di¡erent UVB
£uences at both 24 h (left panel) and 48 h (right panel) after the UVB exposure andY-axis represents PCNA labeling indices. Each bar represents the mean of
six mice, bars, SD (npo0.05, nnpo0.01, nnnpo0.001).
402 GONZAŁ LEZ ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
animals irradiated with 40 and 80 mJ per cm2 UVB. At lower
(40 mJ per cm2) UVB dose mice fed with 0.04% (black bars)
lutein and zeaxanthin also showed an approximately 29%
decrease in PCNA protein levels, which was not statistically
signi¢cant (Fig 4b, left panel). Lutein and zeaxanthin
supplementation did not have any e¡ect on PCNA protein levels
after the highest (160 mJ per cm2) UVB dose (Fig 4b, right
panel). Of note, slightly di¡erent results of PCNA expression in
immunohistochemical and western blot analysis, are most likely
due to our methodologic approach of counting PCNA-positive
cells only in the basal layer (immunochemistry), whereas the
entire epidermal sheets were processed for western blot analysis.
Oral administration of lutein and zeaxanthin reduces UVB-
induced increase in BrdU incorporation into basal epidermal
keratinocytes To evaluate the number of proliferating basal
keratinocytes that are predominantly in the S-phase of cell cycle
we measured the BrdU incorporation into the DNA of basal
keratinocytes.
In unirradiated mice skin, only a fraction of basal keratinocytes
was found in the S-phase, as shown by BrdU incorporation (Fig
5a1). UVB exposure alone increased BrdU incorporation into
epidermal DNA in a dose-dependent manner and these
increases were 2- to 4-fold the baseline values (Fig 5a2).
Signi¢cantly lower numbers of BrdU-positive cells were
observed in animals fed with 0.04% (Fig 5a3) and 0.4% (Fig
5a4) lutein and zeaxanthin at all given UVB doses. To calculate
the BrdU incorporation index only the fraction of basal BrdU-
positive cells were counted. The percentage of BrdU-positive
basal cells was reduced in samples obtained from lutein and
zeaxanthin fed mice 24 and 48 h after UVB irradiation (Fig 5b).
This decrease in the percentage of BrdU-positive basal keratinocytes
was lutein and zeaxanthin concentration dependent. At 24 h (left
panel) and 48 h (right panel) after UVB exposure, the increase in
the percentage of BrdU-positive cells was signi¢cantly reduced
for all UVB doses tested in mice receiving 0.04% (black bars)
and 0.4% (striped bars) lutein and zeaxanthin (po0.05).
DISCUSSION
To our knowledge, this is one of the ¢rst in vivo studies evaluating
at cutaneous cellular level the protective e¡ects of oral intake of
lutein and zeaxanthin against epidermal hyperproliferation and
in£ammation induced by single exposure doses of UVB radia-
tion. An acute exposure of human or murine skin to UVB radia-
tion from natural sunlight or arti¢cial light sources results in
various biologic responses, through the direct formation of cyclo-
butane pyrimidine dimers and (6^4)pyrimidine pyrimidone di-
mers in DNA (Cadet and Vigny, 1990; Cadet et al, 1992). UVB
exposure also results in the formation of free radicals and ROS
that damage DNA and non-DNA cellular targets. Among the lat-
ter, lipid-rich cellular membranes are particularly vulnerable to
the deleterious e¡ects of ROS. These biologic changes include
cell cycle arrest, apoptosis, cell proliferation, and reparative hyper-
plasia during the early adaptive response and are considered to be
involved in the pathophysiology of the UV-induced erythema,
premature skin aging, and skin cancer (Norris et al, 1993; Young,
1993). In recent years, our research interest has been focusing on
minimizing the adverse acute and chronic UV responses using
natural antioxidants known to act as radical scavengers and radical
quenchers in vivo (Gonza¤ lez and Pathak, 1996; Gonza¤ lez et al,
1997). In this study, we showed that supplementation of diets
with 0.4% and 0.04% lutein and zeaxanthin for a period of 2
wk reduced UV-induced increases in the number of apoptotic
cells and proliferating cells in the epidermis of the hairless albino
(SKh-1) mouse model when exposed to graded doses of UVB
radiation.
Only few studies in the past several years have reported the
bene¢cial antioxidant properties of certain carotenoids in photo-
protection of skin against UV radiation (Mathews-Roth et al,
1970, 1972; Stahl et al, 2000). Recently, Granstein and his cowor-
kers1 reported an anti-in£ammatory e¡ect of lutein in the skin of
mice exposed to UV radiation. Mice were fed diets containing
0.04% and 0.4% lutein for 2 wk; ears were then exposed to
UVB radiation to induce in£ammation. The thickness of ear skin
of mice before and 24 h after UV radiation was evaluated.The ear
swelling in response to UV radiation was signi¢cantly inhibited
in the mice fed lutein diet relative to the controls receiving no
dietary supplementation of lutein and zeaxanthin. In our studies
reported here we have con¢rmed these observations. Stahl et al
(2000) examined the e¡ect of carotenoids (mainly b-carotene)
and carotenoids plus vitamin E on the skin of human volunteers
on the development of erythema after exposure to UV radiation.
The erythematous response was signi¢cantly reduced after 8 wk
of supplementation with a carotenoid mixture that included
b-carotene and a small fraction of lutein. The ability of b-caro-
tene, lutein, and astaxanthin to protect against UVA-induced oxi-
dative stress in cultured rat kidney ¢broblasts was also recently
reported by O’Connor and O’Brien (1998). Activities of antioxi-
dant enzymes, such as catalase and superoxide dismutase, as well
Figure 4. (a) Western blot analysis of PCNA and b-actin protein ex-
pression in unirradiated and UVB irradiated skin of mice fed with
either normal diet or lutein and zeaxanthin enriched diet at various
irradiation doses and at di¡erent time points. (b) Western blot analysis
of autoradiographs from each of the three experiments were subjected to
densitometric analysis of band intensity. X-axis represents the di¡erent
UVB £uences, Y-axis indicates the PCNA protein level. Loading was ad-
justed for b-actin protein expression. Clear bars represent mice of group I
without dietary supplementation, black bars show the results of group II
with 0.04% lutein and zeaxanthin and the striped bars represents animals
of group III with 0.4% dietary lutein and zeaxanthin. Each bar represents
the mean of three animals, bars, SD (npo0.05).
1Granstein RD, Faulhaber D, Ding W: Lutein inhibits UVB radiation-
induced tissue swelling and suppression of the induction of contact hyper-
sensitivity (CHS) in the mouse. J Invest Dermatol 117(2):497, 2001 (Abstr.)
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as thiobarbituric reactive substance were evaluated to ascertain
enzymatic changes resulting from oxidative stress induced by
UVA radiation. b-carotene, lutein, and astaxanthin were found
to protect against enzymatic changes with astaxanthin exhibiting
superior photoprotective properties (O’Connor and O’Brien,
1998).
Lutein and zeaxanthin, nonprovitamin A carotenoids, are the
predominant carotenoids found in human retina and their con-
centration is greatest in the fovea centralis of the macula lutea of
human retina where they constitute the macular pigment and
serve to decrease the risk of age-related macular degeneration
(Beatty et al, 1999; Pratt, 1999) and to protect the retinal pigment
epithelium against a photooxidative damage initiated in part by
light absorption (Snodderly, 1995; Broekmans et al, 2002). There
is good evidence that this protection is due mainly to their anti-
oxidant properties (Handleman and Dratz, 1986; Zhang et al, 1991;
Taylor et al, 1993; Sujak et al, 1999). In vitro lutein and zeaxanthin
has been shown to be more e¡ective than b-carotene in inhibit-
ing auto-oxidation of cellular lipids (Zhang et al, 1991) and in
further protecting against oxidant-induced cell damage (Martin
et al, 1996).
It is becoming more apparent that many of the maladies that
a¡ect human skin are the result of direct and indirect environ-
mental interaction invariably caused by UV radiation. Excessive
and often uncontrolled exposure to terrestrial solar radiation is
harmful to human skin and causes acute sunburn, damage to epi-
dermal and dermal cells, induction of cell death, immune sup-
pression, and eventually skin cancer (Young, 1993). Currently the
most widely accepted method of photoprotection against UV ra-
diation is the use of two or more topical sunscreens containing
UVB and UVA absorbing chemicals that are nonphotolabile
(e.g., octyl methoxy cinnamate, octyl dimethyl amino benzoate,
benzophenones, or avobenzone (parsol 1789), etc.) with or with-
out admixture of UV scattering and re£ecting chemicals (e.g.,
ZnO,TiO2 in micronized form) incorporated in a water-resistant
base. Other approaches, including chemicals with antioxidant
properties such as vitamin C, vitamin E, b-carotene, etc., are also
advocated (Thompson et al, 1993; Naylor et al, 1995; Green et al,
1999; Pathak et al, 1999; Stahl et al, 2000). The in vivo presence of
e¡ective antioxidants such as lutein and zeaxanthin in the skin
prior to UVB irradiation may reduce the deleterious e¡ect of ir-
radiation, most likely by decreasing the generation of UV-in-
duced ROS (Athar et al, 1992; Dalle Carbonare and Pathak,
1992). Although b-carotene has been examined in our labora-
tories in the past (Mathews-Roth et al, 1970; 1972; Greenberg et al,
1990), we feel that the antioxidant lutein is less labile and thus
better than b-carotene in minimizing the photooxidative changes
in the skin. Comparative studies using lutein and b-carotene,
however, have to be done to verify the better photoprotective
properties of lutein and zeaxanthin. Because UV-induced in£am-
mation and hyperproliferation (Pentland et al, 1999; An et al, 2002)
has been strongly involved in UVB carcinogenesis, inhibitory ef-
fects of dietary lutein and zeaxanthin on acute in£ammation, and
epidermal hyperproliferation may have a potential implication
for the prevention of carcinogenesis in chronically UV-exposed
skin.
The authors want to thank Martine Sifakis andWilliam Farinelli for excellent tech-
nical assistance and Kemin Foods L.C. (DesMoines, IA) for funding this study
through a research grant fromThe Skin Cancer Foundation, NewYork.
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